The invention concerns a compound of formula (I), wherein R1 = halogen atom selected in the group consisting of: F, Cl, Br, I, and R2 = H or OH, or a pharmaceutically acceptable isomer, salt and/or solvate thereof, for use in preventing and/or treating chronic fatigue syndrome.
LAUFLUMIDE AND DERIVATIVES THEREOF FOR TREATING CHRONIC FATIGUE SYNDROME AND MYALGIC ENCEPHALOMYELITIS/CHRONIC FATIGUE SYNDROME (ME/CFS)
Emily Samuela Turilli;
2021-01-01
Abstract
The invention concerns a compound of formula (I), wherein R1 = halogen atom selected in the group consisting of: F, Cl, Br, I, and R2 = H or OH, or a pharmaceutically acceptable isomer, salt and/or solvate thereof, for use in preventing and/or treating chronic fatigue syndrome.
File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
